NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

People diagnosed with type 2 diabetes before age 40 face a higher lifetime risk of heart and kidney problems, so may benefit from adding another type of medicine called a GLP-1 receptor agonist (such ...

Diabetes affects millions of people across the United States and around the world. While Type 1 and Type 2 diabetes share a name, they involve different causes, treatment approaches, daily management ...

Doctors should prescribe a sodium-glucose cotransporter-2 (SGLT-2) inhibitor alongside metformin to most patients with newly diagnosed type 2 diabetes, the National Institute for Health and Care ...

Many people with Type 2 diabetes believe cutting sugar alone will fix their blood glucose levels. But is that enough?

A large analysis suggests that not meeting basic activity targets could account for a meaningful share of serious complications in people with type 2 diabetes. The estimates linked physical inactivity ...

Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need to know about the breakthrough and why it matters for the world and for ...

Diabetes is one of the most common chronic metabolic diseases and right now about 415 million people have diabetes, and most ...

Diabetes is often used as an umbrella term that covers both its type 1 and type 2.However, both these types of diabetes are fundamentally different diseases. The one symptom they have in common ...

If you can't start your day without a cosy cup of coffee, this one's for you. Dr London shares how it reduces disease risk.